Great idea for a thread. Seems too many are not interested in this vital aspect.
See here:
I would like to know why, according to this:
https://www.australianclinicaltrials.gov.au/what-clinical-trial/phases-clinical-trials
the phase 2 trials seem quite small.
What are your experiences of how quickly phase 3 trials will start, and possible estimate on how quickly it might get to market?
Given some of the data will be propriety, how detailed might the data that is expected to be presented late this year actually be?
The announcement said it targeted one of the reservoirs. Does anyone know the details on the others that the virus might hide in, and how that affects efficacy?
Cheers.
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $4.84K | 1.645M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 53 | 38513231 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 17321492 | 24 |
View Market Depth
| Last trade - 13.35pm 07/07/2025 (20 minute delay) ? |
| BIT (ASX) Chart |